Romslo I, Høvding G, Hamre E, Laerum O D
Scand J Clin Lab Invest. 1978 Oct;38(6):529-35. doi: 10.3109/00365517809108815.
The clinical and biochemical findings in a patient with erythropoietic protoporphyria are described. The patient had an extreme accumulation of protoporphyria in his erythrocytes and there was a thirty-fold increase in stool protoporphyrin. The patient also had elevated protoporphyrin in serum, bone marrow and liver. The porphyrins of the red blood cells, bone marrow and serum had fluorescence spectra different from that of the liver. Urine showed increased copra-, hepta- and uroporphyrins. Ferrochelatase activity in the bone marrow was less than 20% of that of non-porphyric controls. In spite of the extremely high levels of red cell protoporphyrin, the patient was clinically healthy with modest changes in liver function tests and liver histology. The results are discussed in relation to the development of liver damage and the recent findings of the effect of porphyrins on cell metabolism.
本文描述了一名红细胞生成性原卟啉病患者的临床和生化检查结果。该患者红细胞中原卟啉大量蓄积,粪便中原卟啉增加了30倍。患者血清、骨髓和肝脏中的原卟啉水平也升高。红细胞、骨髓和血清中的卟啉荧光光谱与肝脏中的不同。尿液中粪卟啉、七羧基卟啉和尿卟啉增加。骨髓中铁螯合酶活性不到非卟啉病对照的20%。尽管红细胞原卟啉水平极高,但患者临床健康,肝功能检查和肝脏组织学仅有轻微变化。本文结合肝损伤的发生发展以及卟啉对细胞代谢影响的最新研究结果对这些结果进行了讨论。